Aerocrine Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 107

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $198M

Aerocrine General Information

Description

Developer of a monitoring device for inflammatory airway diseases. The company provides a device to monitor exhaled nitric oxide (NO) from patients with inflammatory airway diseases such as asthma to assess the levels of their ailment and predict exacerbations.

Contact Information

Website
www.aerocrine.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Råsundavägen 18
  • P.O. Box 1024
  • 171 71 Solna
  • Sweden
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Acquirer
NIOX Group
Vertical(s)
TMT, HealthTech, Life Sciences
Corporate Office
  • Råsundavägen 18
  • P.O. Box 1024
  • 171 71 Solna
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aerocrine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 18-Jun-2015 $198M Completed Generating Revenue
4. Debt - General 30-Apr-2013 Completed Generating Revenue
3. PIPE 03-May-2012 Completed Generating Revenue
2. IPO 15-Jun-2007 $32.5M $32.5M Completed Generating Revenue
1. Early Stage VC 01-Jan-1999 Completed Startup
To view Aerocrine’s complete valuation and funding history, request access »

Aerocrine Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • Pending

  • Expiring in next 12 mo

Aerocrine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6155257-B2 Handle device and breath analysis device Active 24-Apr-2012
JP-WO2013161286-A1 Handle device and breath analysis device Active 24-Apr-2012
JP-5667628-B2 Diaphragm device for check valve, check valve including diaphragm device and check valve system Active 08-Jul-2009
JP-2012532298-A Diaphragm device for check valve Active 08-Jul-2009
JP-5235217-B2 How to test device functionality Active 20-Dec-2007 A61B5/091
To view Aerocrine’s complete patent history, request access »

Aerocrine Board Members (9)

Name Representing Role Since
Lars Gustafsson Ph.D Self Board Member
Rolf Classon Self Chairman
You’re viewing 2 of 9 board members. Get the full list »

Aerocrine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aerocrine Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
CapMan PE/Buyout Minority
GZ Group Venture Capital Minority
HealthCap Venture Capital Minority
Novo Holdings Asset Manager Minority
OrbiMed Growth/Expansion Minority
You’re viewing 5 of 7 investors. Get the full list »

Aerocrine Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Apieron 19-May-2010 Monitoring Equipment
To view Aerocrine’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Aerocrine FAQs

  • When was Aerocrine founded?

    Aerocrine was founded in 1997.

  • Where is Aerocrine headquartered?

    Aerocrine is headquartered in Solna, Sweden.

  • What is the size of Aerocrine?

    Aerocrine has 107 total employees.

  • What industry is Aerocrine in?

    Aerocrine’s primary industry is Monitoring Equipment.

  • Is Aerocrine a private or public company?

    Aerocrine is a Private company.

  • What is the current valuation of Aerocrine?

    The current valuation of Aerocrine is .

  • What is Aerocrine’s current revenue?

    The current revenue for Aerocrine is .

  • How much funding has Aerocrine raised over time?

    Aerocrine has raised $81.9M.

  • Who are Aerocrine’s investors?

    CapMan, GZ Group, HealthCap, Novo Holdings, and OrbiMed are 5 of 7 investors who have invested in Aerocrine.

  • When was Aerocrine acquired?

    Aerocrine was acquired on 18-Jun-2015.

  • Who acquired Aerocrine?

    Aerocrine was acquired by NIOX Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »